Abstract
Opioid use disorder (OUD) has emerged as a significant global public health issue, necessitating the discovery of new medications. In this study, we propose a deep generative model that combines a stochastic differential equation (SDE)-based diffusion model with a pretrained autoencoder. The molecular generator enables efficient generation of molecules that target multiple opioid receptors, including mu, kappa, and delta. Additionally, we assess the ADMET (absorption, distribution, metabolism, excretion, and toxicity) properties of the generated molecules to identify druglike compounds. We develop a molecular optimization approach to enhance the pharmacokinetic properties of some lead compounds. Advanced binding affinity predictors were built using molecular fingerprints, including autoencoder embeddings, transformer embeddings, and topological Laplacians. Our process yields druglike molecules that can be used in highly focused experimental studies to further evaluate their pharmacological effects. Our machine learning platform serves as a valuable tool for designing effective molecules to address OUD.
Original language | English |
---|---|
Pages (from-to) | 12479-12498 |
Number of pages | 20 |
Journal | Journal of Medicinal Chemistry |
Volume | 66 |
Issue number | 17 |
DOIs | |
State | Published - Sep 14 2023 |
Bibliographical note
Publisher Copyright:© 2023 American Chemical Society
Funding
This work was supported in part by NIH grants R01GM126189, R01AI164266, R35GM148196, and R01Move to C24F390AI164266, NSF grants DMS-2052983, DMS-1761320, DMS-2245903, and IIS-1900473, NASA grant 80NSSC21M0023, MSU Foundation, Bristol-Myers Squibb 65109, and Pfizer.
Funders | Funder number |
---|---|
National Science Foundation (NSF) | DMS-2245903, IIS-1900473, DMS-2052983, DMS-1761320 |
National Institutes of Health (NIH) | R35GM148196, R01GM126189, R01AI164266 |
National Aeronautics and Space Administration | 80NSSC21M0023 |
Bristol-Myers Squibb | 65109 |
Pfizer | |
Michigan State University Foundation |
ASJC Scopus subject areas
- Molecular Medicine
- Drug Discovery